Nu Clarity

Nu Clarity

CogniTune Smarter Health4.3 (285 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 30 servings
Goals
$19.97 $0.66 per serving

Product analysis

52 out of 100

Nu Clarity combines ingredients with possible roles in memory, focus and stress support. Findings depend on particular extracts and amounts, so the blend does not establish a dependable improvement in everyday mental performance.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality41

Rhodiola rosea is specifically identified, which helps confirm the plant used. Several other forms remain unclear, and the named plant compounds do not establish equivalence with tested extracts.

Ingredient Transparency63

All ingredient amounts are stated, but several forms are unspecified. Missing breakdowns for ginkgo and rhodiola also make their composition harder to compare.

Value For Money40

Bacopa and huperzine offer middling value in their respective comparisons, while rhodiola is relatively costly for its amount. Comparisons for the remaining ingredients are too limited to establish the value of the full blend.

Customer Satisfaction66

Customer ratings are generally positive across a moderate number of reviews. They describe satisfaction without establishing improvements in memory, focus or mood.

Product Focus63

The ingredients have possible links to memory, attention and stress, but benefits depend on the preparations and amounts used. Unclear extract identities and active amounts limit expectations for a reliable everyday effect.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.66
Customer rating
4.3 · 285 ratings
Report analysis

Goals

Brain Health
Impact
Highest effect
B Ingredient FitB+ PathwaysB EvidenceA+ Formulation Logic
Huperzine · 100 mcgBacopa · 300 mgAlpha-GPC · 200 mg
Study evidence
Alpha-GPC Supportive 12 studies
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Huperzine Supportive 17 studies
Rhodiola Supportive 8 studies
Cognitive Support
Impact
Highest effect
B+ Ingredient FitB+ PathwaysB- EvidenceA+ Formulation Logic
Huperzine · 100 mcgAlpha-GPC · 200 mgBacopa · 300 mg
Study evidence
Alpha-GPC Supportive 15 studies
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Huperzine Supportive 22 studies
Rhodiola Supportive 7 studies
Impact
Moderate effect
B+ Ingredient FitC+ PathwaysD- EvidenceA+ Formulation Logic
Alpha-GPC · 200 mgHuperzine · 100 mcg
Study evidence
Alpha-GPC Supportive 1 study
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Huperzine Not classified

No linked studies yet.

Rhodiola Supportive 15 studies
Stress Relief
Impact
High effect
C Ingredient FitB- PathwaysC+ EvidenceA+ Formulation Logic
Study evidence
Bacopa Supportive 8 studies
Rhodiola Supportive 16 studies
Mood Support
Impact
Moderate effect
C- Ingredient FitF PathwaysB EvidenceA+ Formulation Logic
Study evidence
Alpha-GPC Supportive 1 study
Bacopa Supportive 7 studies
Rhodiola Supportive 15 studies
Productivity Boost
Impact
Moderate effect
B Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Huperzine · 100 mcgAlpha-GPC · 200 mg
Study evidence
Alpha-GPC Supportive 2 studies
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Rhodiola Supportive 7 studies
Energy
Impact
Lower effect
D- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Study evidence
Rhodiola Supportive 18 studies

Ingredients

IngredientAmount per servingScore
Bacopa Monnieri Extract (Bacosides)
300 mg 83
Alpha-GPC
200 mg 33
N-Acetyl-L Carnitine HCl
150 mg
Phosphatidylserine
100 mg
Ginkgo Biloba Leaf Extract (Glycosides, Lactones)
100 mg 71
Rhodiola rosea Extract (Rosavins, Salidrosides)
100 mg 78
Huperzine A
100 mcg 53
Gluten Free Adults 18–50 Vegan Women Vegetarian
Report overview
Huperzine · 100 mcg OverallScore53
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD+ Value
100 mcg of Huperzine A per serving falls in the range most associated with cognitive focus, and the cost for that amount is moderate. Source and extract details are unclear. Cycling instructions are not available.
How this ingredient is rated

Active Ingredient Quality & Bioavailability20

Huperzine A is named, but its source, extract and concentration details are unclear.
Source and Standardization Clarity
Huperzine A is named, but its source, extract and concentration details are unclear.

Dose, Safety & Label Transparency88

100 mcg of Huperzine A per serving falls in the range most associated with cognitive focus. Cycling instructions are not available.
Huperzine A Dosage Efficacy
100 mcg of Huperzine A per serving falls in the range most associated with cognitive focus.
Cycling Guidance and Transparency
The Huperzine A amount is stated, but cycling instructions are not available.

Value50

The cost is moderate for the amount of Huperzine A.
Price per 100mcg of Huperzine A
The cost is moderate for the amount of Huperzine A.
B+ Composition And Label DisclosureA+ Composition And Label DisclosureF Commercial Price And Usability
The serving provides 100 mg of Rhodiola rosea Extract. The whole-product price is relatively high for the stated amount of rhodiola. 1% rosavins and 3% salidrosides are stated.
How this ingredient is rated

Composition and Label Disclosure84

The species is Rhodiola rosea. 1% rosavins and 3% salidrosides are stated.
Declared Rhodiola Marker Profile
1% rosavins and 3% salidrosides are stated.
Rhodiola Species Detail
The species is Rhodiola rosea.

Composition and Label Disclosure100

The amount is stated for the serving. No flagged flow agents or artificial additives are recorded; this does not establish purity.
Rhodiola Amount Disclosure
The serving contains 100 mg of rhodiola.
Other Ingredients Disclosure
No flagged flow agents or artificial additives are recorded; this does not establish purity.

Commercial Price and Usability20

The whole-product price is relatively high for the stated amount of rhodiola.
Cost per 200 mg Declared Rhodiola
The whole-product price is relatively high for the stated amount of rhodiola.
A+ Composition And Label DisclosureD+ Commercial Price And Usability
A serving states 300 mg of bacopa monnieri extract. It states 20% bacosides. The whole-product price per serving is moderately high.
How this ingredient is rated

Composition and Label Disclosure

No composition details were assessed in this group.

Composition and Label Disclosure100

A serving states 300 mg of bacopa monnieri extract. It states 20% bacosides.
Amount and Label Disclosure
A serving states 300 mg of bacopa monnieri extract. It states 20% bacosides.

Commercial Price and Usability50

The whole-product price per serving is moderately high.
Commercial Price per Labeled Serving
The whole-product price per serving is moderately high.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledBrain Health Cognitive Support forAlpha-GPC
  7. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsBrain Health Cognitive Support forAlpha-GPC
  8. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsBrain Health Cognitive Support forAlpha-GPC
  9. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsBrain Health Mental Focus Productivity Boost forAlpha-GPC
  10. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsBrain Health forAlpha-GPC
  11. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledBrain Health Mental Focus forBacopa
  12. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  13. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  14. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  15. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledBrain Health Cognitive Support forBacopa
  16. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  17. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  18. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  19. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  20. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo